Palantir sits at the center of the rush to turn messy data into decisions, with deep ties to government work and a growing list of big-name corporate customers. If demand for these tools keeps spreading across industries, it could become a go-to platform—but its heavy focus on defense-related use also shapes the risks.Read more

*DISCLAIMER: *This article is NOT financial advice of any kind, i am NOT a financial adviser, this content should NOT be construed as an offer, recommendation or inducement to buy or sell Greenwich Lifesciences $GLSI stock. Do yor own Due diligence with this type of products before taking from granted any of these opinions.Read more